Copyright
©The Author(s) 2016.
World J Hepatol. Apr 8, 2016; 8(10): 471-484
Published online Apr 8, 2016. doi: 10.4254/wjh.v8.i10.471
Published online Apr 8, 2016. doi: 10.4254/wjh.v8.i10.471
Figure 4 “Angiogenic switch” in hepatocellular carcinoma.
VEGF: Vascular endothelial growth factor; HCC: Hepatocellular carcinoma; HIF 1: Hypoxia inducible factor 1.
- Citation: Kim JU, Shariff MIF, Crossey MME, Gomez-Romero M, Holmes E, Cox IJ, Fye HKS, Njie R, Taylor-Robinson SD. Hepatocellular carcinoma: Review of disease and tumor biomarkers. World J Hepatol 2016; 8(10): 471-484
- URL: https://www.wjgnet.com/1948-5182/full/v8/i10/471.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i10.471